Aquestive Therapeutics, Inc. (AQST) stock
AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.70−0.06 (-1.60%)
Close on Nov 17, 2026Market cap $464.39MP/E –Yield –
Aquestive Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Aquestive Therapeutics's total debt was $50.69M at Jun 30, 2026. For fiscal 2025 it was $37.51M, up 15.4% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.51M | +15.4% |
| FY2024 | Dec 31, 2024 | $32.50M | +18.1% |
| FY2023 | Dec 31, 2023 | $27.51M | -17.8% |
| FY2022 | Dec 31, 2022 | $33.45M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $50.69M | +84.3% |
| Q1 FY2026 | Mar 31, 2026 | $25.10M | -25.0% |
| Q4 FY2025 | Dec 31, 2025 | $37.51M | – |
| Q4 FY2024 | Dec 31, 2024 | $32.50M | – |
| Q4 FY2023 | Dec 31, 2023 | $27.51M | – |
| Q4 FY2022 | Dec 31, 2022 | $33.45M | – |
See a number that looks wrong?